Sierra Oncology Inc (SRRA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

2150 ? 885 WEST GEORGIA STREET VANCOUVER, BRITISH COLUMBIA, CANADA V6C 3E8

Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. Sierra Oncology harnesses its deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies with assets on the leading edge of cancer biology. Its team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact.

Data as of 2021-07-25 17:20:27 -0400
Market Cap241.442 Million Shares Outstanding12.35 Million Avg 30-day Volume22.814 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-12.72 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.51046 52-week High/Low23.85 / 10.02 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -11.3673
Data provided by IEX Cloud
View SEC Filings from SRRA instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 3 0.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 33 31 6.45% 20 (1.17%) 21 (1.22%) -4.76%
13F shares: 8.703 Million 7.603 Million 14.48% 7.293 Million 5.996 Million 21.62%
% Ownership 74.8452 68.8611 8.69% 62.7136 54.3091 15.48%
New Positions: 4 6 -33.33% 1 6 -83.33%
Increased Positions 11 5 120.0% 9 4 125.0%
Closed Positions 2 2 0.0% 2
Reduced Positions 6 7 -14.29% 3 4 -25.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SRRA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SRRA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PELZER ROBERT

  • Director
6,000 2021-06-08 1

COOPER JEFFREY H

  • Director
6,000 2021-06-08 1

ALLEN ANDREW R

  • Director
6,000 2021-06-08 1

AGGARWAL GAURAV

  • Director
  • 10% Owner
6,000 2021-06-08 1

ASHIYA MONA

  • Director
  • 10% Owner
6,000 2021-06-08 1

RICHARDSON JOSHUA

  • Director
  • 10% Owner
6,000 2021-06-08 1

SINCLAIR ANDREW

  • Director
6,000 2021-06-08 1

COLLARD CRAIG A

  • Director
6,000 2021-06-08 1

ERBEZ GEORGIA

  • Director
0 2021-06-02 2

OLIGER CHRISTY J.

  • Director
18,000 2021-06-02 2

DILLY STEPHEN GEORGE CEO AND PRESIDENT

  • Officer
  • Director
5,000 2021-05-19 2

JAGPAL SUKHI CHIEF FINANCIAL OFFICER

  • Officer
30,000 2021-03-15 2

KLENCKE BARBARA CHIEF DEVELOPMENT OFFICER

  • Officer
30,000 2021-03-15 2

KOWALSKI MARK CHIEF MEDICAL OFFICER

  • Officer
30,000 2021-03-15 2

THOMSON CHRISTINA GENERAL COUNSEL

  • Officer
12,900 2021-03-15 1

TURNER WILLIAM D. CHIEF REG & TECH OPS OFFICER

  • Officer
12,300 2021-03-15 3

NORRETT KEVIN CHIEF BUSINESS OFFICER

  • Officer
11,700 2021-03-15 3

THOMSON MARY CHRISTINA GENERAL COUNSEL

  • Officer
12,900 2021-03-15 1

GLOVER NICHOLAS CEO AND PRESIDENT

  • Officer
  • Director
0 2020-02-25 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VII LLC

ORBIMED GLOBAL HEALTHCARE GP LLC

ORBIMED CAPITAL LLC

  • Director
  • 10% Owner
1,477,320 2020-01-29 0

LONGITUDE CAPITAL PARTNERS III, LLC

LONGITUDE VENTURE PARTNERS III, L.P.

TAMMENOMS BAKKER JULIET

ENRIGHT PATRICK G

  • 10% Owner
1,477,320 2020-01-29 0

VIVO OPPORTUNITY, LLC

VIVO OPPORTUNITY FUND, L.P.

VIVO CAPITAL IX, LLC

VIVO CAPITAL FUND IX, L.P.

VIVO VENTURES VII, LLC

VIVO VENTURES FUND VII, L.P.

VIVO VENTURES VII AFFILIATES FUND, L.P.

  • 10% Owner
1,917,074 2020-01-29 0

ONETTO NICOLE

  • Director
0 2019-06-11 0

PARFET DONALD R

  • Director
0 2019-06-11 0

NGUYEN TRAN

  • Director
0 2019-06-11 0

ESTES DANIEL

  • Director
0 2019-06-11 0

HASSIG CHRISTIAN CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-03-04 0

YOU ANGIE CHIEF BUS. & STRAT. OFFICER

  • Officer
0 2018-03-06 0

TOPPER JAMES N

  • Director
  • 10% Owner
8,112,121 2017-02-14 0

FRAZIER HEALTHCARE VI, L.P.

FHM VI, L.P.

FHM VI, L.L.C.

FRAZIER LIFE SCIENCES VIII, L.P.

FHM LIFE SCIENCES VIII, L.P.

FHM LIFE SCIENCES VIII, L.L.C.

FRAZIER ALAN D

NAINI NADER J

EVERY NATHAN R

HERON PATRICK J

  • 10% Owner
8,112,121 2017-02-14 0

CHAPMAN WENDY SVP CLINICAL OPERATIONS

  • Officer
0 2016-03-22 0

LOVEJOY CHANDRA D SVP OF REG. AFFAIRS & QUALITY

  • Officer
0 2016-03-08 0

MESSMANN RICHARD A CHIEF MEDICAL OFFICER

  • Officer
0 2016-03-08 0

RODIGUEZA WENDI CHIEF SCIENTIFIC OFFICER

  • Officer
156,276 2016-01-20 0

ANDERSON KEITH EDWARD SVP, TECHNICAL OPERATIONS

  • Officer
0 2015-12-01 0

CHA ALBERT

  • Director
2,438,270 2015-07-21 0

ORBIMED ADVISORS LLC

ISALY SAMUEL D

ORBIMED PRIVATE INVESTMENTS V, LP

  • Director
1,989,949 2015-07-21 0

THOMPSON PETER A.

  • Director
1,989,949 2015-07-21 0

VITANGCOL ALVIN

  • Director
798,762 2015-07-21 0

VIVO VENTURES VII, LLC

VIVO VENTURES FUND VII, L.P.

VIVO VENTURES VII AFFILIATES FUND, L.P.

  • FORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDER
No longer subject to file 2015-07-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

RICHARDSON JOSHUA - Director - > 10% Owner

2021-06-09 10:19:25 -0400 2021-06-08 A 6,000 a 6,000 direct

PELZER ROBERT - Director

2021-06-09 10:38:25 -0400 2021-06-08 A 6,000 a 6,000 direct

AGGARWAL GAURAV - Director - > 10% Owner

2021-06-09 10:29:38 -0400 2021-06-08 A 6,000 a 6,000 direct

COOPER JEFFREY H - Director

2021-06-09 10:52:08 -0400 2021-06-08 A 6,000 a 6,000 direct

ASHIYA MONA - Director - > 10% Owner

2021-06-09 10:36:58 -0400 2021-06-08 A 6,000 a 6,000 direct

SINCLAIR ANDREW - Director

2021-06-09 10:24:15 -0400 2021-06-08 A 6,000 a 6,000 direct

COLLARD CRAIG A - Director

2021-06-09 10:50:39 -0400 2021-06-08 A 6,000 a 6,000 direct

ALLEN ANDREW R - Director

2021-06-09 10:31:42 -0400 2021-06-08 A 6,000 a 6,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SIERRA ONCOLOGY INC SRRA 2021-08-02 18:45:03 UTC -0.827 0.887 30000
SIERRA ONCOLOGY INC SRRA 2021-08-02 18:15:03 UTC -0.827 0.887 30000
SIERRA ONCOLOGY INC SRRA 2021-08-02 17:45:03 UTC -0.827 0.887 30000
SIERRA ONCOLOGY INC SRRA 2021-08-02 17:15:03 UTC -0.827 0.887 30000
SIERRA ONCOLOGY INC SRRA 2021-08-02 16:45:03 UTC -0.8207 0.9007 30000
SIERRA ONCOLOGY INC SRRA 2021-08-02 16:15:03 UTC -0.8207 0.9007 15000
SIERRA ONCOLOGY INC SRRA 2021-08-02 15:45:03 UTC -0.8207 0.9007 15000
SIERRA ONCOLOGY INC SRRA 2021-08-02 15:15:03 UTC -0.8207 0.9007 15000
SIERRA ONCOLOGY INC SRRA 2021-08-02 14:45:03 UTC -0.8207 0.9007 15000
SIERRA ONCOLOGY INC SRRA 2021-08-02 14:15:03 UTC -0.8207 0.9007 15000
SIERRA ONCOLOGY INC SRRA 2021-08-02 13:45:03 UTC -0.8207 0.9007 15000
SIERRA ONCOLOGY INC SRRA 2021-08-02 13:15:04 UTC -0.8207 0.9007 15000
SIERRA ONCOLOGY INC SRRA 2021-08-02 12:45:03 UTC -0.8207 0.9007 15000
SIERRA ONCOLOGY INC SRRA 2021-07-30 22:15:02 UTC -0.8207 0.9007 30000
SIERRA ONCOLOGY INC SRRA 2021-07-30 21:45:03 UTC -0.8207 0.9007 30000
SIERRA ONCOLOGY INC SRRA 2021-07-30 21:15:03 UTC -0.8207 0.9007 30000
SIERRA ONCOLOGY INC SRRA 2021-07-30 20:45:02 UTC -0.8207 0.9007 30000
SIERRA ONCOLOGY INC SRRA 2021-07-30 20:15:02 UTC -0.8207 0.9007 30000
SIERRA ONCOLOGY INC SRRA 2021-07-30 19:45:03 UTC -0.8207 0.9007 30000
SIERRA ONCOLOGY INC SRRA 2021-07-30 19:15:02 UTC -0.8207 0.9007 30000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
Morgan Stanley Alphamab Oncology - B 2.99% 2020-01-07 Hong Kong

Short Position History (International Only)

Holder Net Short Position Position Date Origin
Morgan Stanley Alphamab Oncology - B 2.99% 2019-12-23 Hong Kong
Morgan Stanley Alphamab Oncology - B 2.99% 2020-01-03 Hong Kong
Morgan Stanley Alphamab Oncology - B 2.99% 2020-01-04 Hong Kong
Morgan Stanley Alphamab Oncology - B 2.99% 2019-12-19 Hong Kong

Elevate your investments